Abhishek Rajesh Indurkar

Mr. Abhishek Rajesh Indurkar

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2021 in Bioprinting
Verified
Journal Article
Closed access
AIAbhishek Rajesh Indurkar
Abhishek Rajesh Indurkar
APAshish Pandit
Ashish Pandit
RJRatnesh Jain
Ratnesh Jain
PDPrajakta Dandekar
Prajakta Dandekar

1 December 2020 in Bioprinting
Verified
Journal Article
Closed access
AIAbhishek Rajesh Indurkar
Abhishek Rajesh Indurkar
PBPrachi Bangde
Prachi Bangde
MGManish Gore
Manish Gore
PRParivarthan Reddy
Parivarthan Reddy
RJRatnesh Jain
Ratnesh Jain
PDPrajakta Dandekar
Prajakta Dandekar

15 October 2021 in Materials
Verified
Journal Article
Open access
PDF file
AIAbhishek Rajesh Indurkar
Abhishek Rajesh Indurkar
Rajan ChoudharyRajan Choudhary
Rajan Choudhary
KRKristaps Rubenis
Kristaps Rubenis
JLJanis Locs
Janis Locs
Calcium phosphate (CaP) biomaterials are extensively used to reconstruct bone defects. They resemble a chemical similarity to the inorganic mineral present in bones. Thus, they are termed as the key players in bone regeneration. Sintering is a heat treatment process applied to CaP powder compact or fabricated porous material to impart strength and integrity. Conventional sintering is the simplest sintering technique, but the processing of CaPs at a high temperature for a long time usually leads to the formation of secondary phases due to their thermal instability. Furthermore, it results in excessive grain growth that obstructs the densification process, limiting the application of CaP’s ceramics in bone regeneration. This review focuses on advanced sintering techniques used for the densification of CaPs. These techniques utilize the synergy of temperature with one or more parameters such as external pressure, electromagnetic radiation, electric current, or the incorporation of transient liquid that boosts the mass transfer while lowering the sintering temperature and time.

16 March 2018 in IET Nanobiotechnology
Verified
Journal Article
Open access
PDF file
AIAbhishek Rajesh Indurkar
Abhishek Rajesh Indurkar
VSViraj D. Sangoi
Viraj D. Sangoi
PPPrashant B. Patil
Prashant B. Patil
MNMansingraj S. Nimbalkar
Mansingraj S. Nimbalkar
Here, the authors report a rapid, simple, and eco‐friendly process for synthesis of Bi 2 O 3 nano‐needles. Dioscorea alata tuber extract was used as both reducing and capping agent for the first time. These nanoparticles were characterised by X‐ray diffraction, field emission scanning electron microscope, and Fourier transform infrared (FTIR) spectrometry, the nano‐structured Bi 2 O 3 needles have an average diameter of 158 nm with the lengths in the range of 1–3 μm. CLSI M27‐A2 standard was followed for evaluation of anti‐fungal activity. Bi 2 O 3 nano‐needles show remarkable activity against Candida albicans . It exhibits four time greater activity than bulk Bi 2 O 3 powder and two time greater activity than itraconazole, which makes it a potent anti‐fungal drug.

20 May 2019 in IET Nanobiotechnology
Verified
Journal Article
Open access
PDF file
AIAbhishek Rajesh Indurkar
Abhishek Rajesh Indurkar
VSViraj D. Sangoi
Viraj D. Sangoi
NMNikhil D. Moon
Nikhil D. Moon
MNMansingraj S. Nimbalkar
Mansingraj S. Nimbalkar
In this study, the synthesis of ultra‐fine grade antimony trioxide (Sb 2 O 3 ) using plant extract for the first time is reported. Antimony chloride was used as a starting material and Dioscorea alata tuber extract was used as a reducing and capping agent. The synthesised nanoparticles were characterised by X‐ray diffraction (XRD), field emission scanning electron microscopy (FE‐SEM), dynamic light scattering (DLS), and Fourier transform infrared spectroscopy. XRD analysis indicates the formation of pure Sb 2 O 3 nanoparticles. The result from FE‐SEM and DLS showed that the particles have a cube‐like morphology and have an average size of 346.4 nm which falls within the range of ultra‐fine grade Sb 2 O 3 .

14 August 2024 in ACS Omega
Verified
Journal Article
Open access
RCRajan Choudhary
Rajan Choudhary
AIAbhishek Rajesh Indurkar
Abhishek Rajesh Indurkar
KRKristaps Rubenis
Kristaps Rubenis
AGAndra Grava
Andra Grava
ADArita Dubnika
Arita Dubnika
JLJanis Locs
Janis Locs
Octacalcium phosphate (OCP) has excellent bone formation ability and a good resorption rate as compared to the commercial bone substitutes [e.g., Bio-Oss (Geistlich Pharma AG) and MBCP+ (Biomatlante)], as well as synthesized biomaterials (hydroxyapatite and tricalcium phosphate). The synthesis approach to obtain phase-pure OCP possesses a great challenge due to its complex reaction mechanism and narrow synthesis window. Thus, the current study aimed to overcome the synthesis challenges and to define the precise reaction conditions required for controllable and reproducible synthesis of OCP. Using the principles of the coprecipitation method, novel synthesis protocols were developed ensuring ultrafast synthesis of OCP within minutes. XRD analysis confirmed that phase-pure OCP was obtained. These processing schemes enabled the synthesis of tailor-made OCP with specific surface areas ranging from 16 to 91 m2/g. The synthesized OCPs exhibited plate-like morphology. The interaction of the synthesized OCPs with MC3T3-E1 cells was found to be nontoxic, confirming their cytocompatibility. The synthesis approach developed in this study indicates that challenges such as the reaction volume, stirring rate, and flow rate need to be addressed in the future to upscale the technology.